Witnesses Voice Support For Biologic Pathway
A number of drug makers and the Food and Drug Administration told lawmakers Monday that the agency has the ability to evaluate at least some generic or follow-on biologic products....To view the full article, register now.
Already a subscriber? Click here to view full article